Perceptive Advisors as of Dec. 31, 2011
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 66 positions in its portfolio as reported in the December 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Pharmasset | 13.4 | $58M | 452k | 128.20 | |
Celgene Corporation | 11.2 | $49M | 721k | 67.60 | |
Ariad Pharmaceuticals | 8.7 | $38M | 3.1M | 12.25 | |
Neurocrine Biosciences (NBIX) | 6.5 | $28M | 3.3M | 8.50 | |
Allergan Inc Com Stk | 6.1 | $26M | 300k | 87.74 | |
Aegerion Pharmaceuticals | 4.8 | $21M | 1.3M | 16.74 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 4.8 | $21M | 627k | 32.91 | |
Seattle Genetics | 3.2 | $14M | 820k | 16.72 | |
Shire | 3.0 | $13M | 126k | 103.90 | |
Repros Therapeutics | 2.6 | $11M | 2.3M | 4.82 | |
Endo Pharmaceuticals | 2.5 | $11M | 312k | 34.53 | |
Capital Senior Living Corporation | 2.4 | $10M | 1.3M | 7.94 | |
Novartis (NVS) | 2.2 | $9.7M | 170k | 57.17 | |
Amgen | 2.2 | $9.5M | 148k | 64.21 | |
Medivation | 2.1 | $9.2M | 201k | 46.11 | |
Biogen Idec (BIIB) | 1.8 | $7.7M | 70k | 110.06 | |
Mylan | 1.6 | $6.9M | 320k | 21.46 | |
Trius Therapeutics | 1.5 | $6.6M | 921k | 7.15 | |
Neptune Technologies Bioreso | 1.5 | $6.4M | 2.7M | 2.36 | |
Thoratec Corporation | 1.4 | $6.3M | 187k | 33.56 | |
AVI BioPharma ComStk Usd0.0001 | 1.0 | $4.3M | 5.8M | 0.74 | |
Array BioPharma | 1.0 | $4.2M | 1.9M | 2.16 | |
WellPoint | 0.9 | $4.0M | 60k | 66.25 | |
Hospira | 0.9 | $3.9M | 128k | 30.37 | |
Regeneron Pharmaceuticals (REGN) | 0.8 | $3.3M | 60k | 55.43 | |
Express Scripts | 0.7 | $3.1M | 70k | 44.69 | |
NPS Pharmaceuticals | 0.7 | $3.1M | 475k | 6.59 | |
Pharmacyclics | 0.7 | $3.0M | 202k | 14.82 | |
Human Genome Sciences | 0.7 | $3.0M | 400k | 7.39 | |
Perrigo Company | 0.7 | $2.9M | 30k | 97.30 | |
Medtronic | 0.7 | $2.9M | 75k | 38.25 | |
Gilead Sciences (GILD) | 0.6 | $2.7M | 66k | 40.93 | |
Targacept | 0.6 | $2.5M | 450k | 5.57 | |
Athersys | 0.6 | $2.5M | 1.5M | 1.73 | |
Optimer Pharmaceuticals | 0.6 | $2.4M | 200k | 12.24 | |
Onyx Pharmaceuticals | 0.5 | $2.1M | 48k | 43.96 | |
Chelsea Therapeutics International | 0.5 | $2.1M | 400k | 5.13 | |
Progenics Pharmaceuticals | 0.4 | $1.7M | 201k | 8.54 | |
EXACT Sciences Corporation (EXAS) | 0.4 | $1.6M | 200k | 8.12 | |
Keryx Biopharmaceuticals | 0.3 | $1.5M | 600k | 2.53 | |
Dendreon Corporation | 0.3 | $1.5M | 200k | 7.60 | |
Cutera (CUTR) | 0.3 | $1.4M | 185k | 7.45 | |
Response Genetics (RGDXQ) | 0.3 | $1.4M | 913k | 1.53 | |
Neostem (NBS) | 0.3 | $1.3M | 2.6M | 0.51 | |
Transcept Pharmaceuticals | 0.3 | $1.2M | 159k | 7.84 | |
Cell Therapeutics | 0.3 | $1.2M | 1.0M | 1.16 | |
Amylin Pharmaceuticals | 0.3 | $1.1M | 100k | 11.38 | |
Trinity Biotech | 0.2 | $1.0M | 101k | 10.18 | |
Affymax (AFFY) | 0.2 | $990k | 150k | 6.61 | |
Vivus | 0.2 | $975k | 100k | 9.75 | |
Solta Medical | 0.2 | $840k | 267k | 3.14 | |
BioSante Pharmaceuticals | 0.1 | $325k | 650k | 0.50 | |
Ampio Pharmaceuticals | 0.1 | $320k | 75k | 4.27 | |
LeMaitre Vascular (LMAT) | 0.1 | $221k | 37k | 5.91 | |
Unilife Corp cs | 0.0 | $187k | 60k | 3.12 | |
Uroplasty | 0.0 | $121k | 28k | 4.26 | |
Curis | 0.0 | $140k | 30k | 4.67 | |
Senesco Technologies | 0.0 | $116k | 446k | 0.26 | |
Clovis Oncology | 0.0 | $141k | 10k | 14.10 | |
Allos Therapeutics | 0.0 | $71k | 50k | 1.42 | |
Orexigen Therapeutics | 0.0 | $25k | 16k | 1.59 | |
Kensey Nash Corporation | 0.0 | $58k | 3.0k | 19.33 | |
MELA Sciences | 0.0 | $37k | 10k | 3.70 | |
MAKO Surgical | 0.0 | $63k | 2.5k | 25.20 | |
Angeion Corporation | 0.0 | $33k | 6.4k | 5.19 | |
Combimatrix Corporation *w exp 05/01/201 | 0.0 | $7.0k | 50k | 0.14 |